http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113461603-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c84b71b532e3fc02117c39e57ca5202
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-61
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-61
filingDate 2021-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6afcb2978fd01daa74c539b42e8992c9
publicationDate 2021-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113461603-A
titleOfInvention Synthetic method of medicine raw material 2, 5-dibromopyridine
abstract The invention relates to the technical field of dibromopyridine preparation, and discloses a synthetic method of a medicine raw material 2, 5-dibromopyridine, which comprises the following steps: s1: heating, namely adding 2-aminopyridine and acetic anhydride into a four-neck flask, heating to reflux, and tracking by thin-layer chromatography until the reaction is complete; s2: cooling, wherein the raw materials in the S1 are cooled after complete reaction, then bromoethane is added for stirring, heating is carried out during stirring, the heating temperature is 30-60 ℃, the heating time is 20-40 minutes, and cooling is carried out again after stirring to obtain a mixture A; s3: liquid bromine is added dropwise. The invention can pre-mix the raw materials, make the raw materials react preliminarily, improve the reaction effect, promote the full reaction with the mixture B, generate bubbles after the reaction, facilitate the next crystallization operation, reduce the cost by accurately controlling the temperature and the raw materials in the process, and is safer and more reliable.
priorityDate 2021-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID817102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453030527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424945193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450649535
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69353
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416086238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415742533

Total number of triples: 42.